Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406
Contents lists available at ScienceDirect
Best Practice & Research Clinical Anaesthesiology
journal homepage: www.elsevier.com/locate/bean
7
Photoplethysmography
Aymen A. Alian, M.D., Associate Professor of Anesthesiology, Kirk H. Shelley, M.D., Ph.D., Professor of Anesthesiology *
Department of Anesthesiology, Yale University School of Medicine, New Haven, CT, USA

Keywords: noninvasive cardiovascular monitor pulse oximeter waveform PPG pleth

The photoplethysmographic (PPG) waveform, also known as the pulse oximeter waveform, is one of the most commonly displayed clinical waveforms. First described in the 1930s, the technology behind the waveform is simple. The waveform, as displayed on the modern pulse oximeter, is an ampliÔ¨Åed and highly Ô¨Åltered measurement of light absorption by the local tissue over time. It is optimized by medical device manufacturers to accentuate its pulsatile components. Physiologically, it is the result of a complex, and not well understood, interaction between the cardiovascular, respiratory, and autonomic systems. All modern pulse oximeters extract and display the heart rate and oxygen saturation derived from the PPG measurements at multiple wavelengths. ‚ÄúAs is,‚Äù the PPG is an excellent monitor for cardiac arrhythmia, particularly when used in conjunction with the electrocardiogram (ECG). With slight modiÔ¨Åcations in the display of the PPG (either to a strip chart recorder or slowed down on the monitor screen), the PPG can be used to measure the ventilator-induced modulations which have been associated with hypovolemia. Research efforts are under way to analyze the PPG using improved digital signal processing methods to develop new physiologic parameters. It is hoped that when these new physiologic parameters are combined with a more modern understanding of cardiovascular physiology (functional hemodynamics) the potential utility of the PPG will be expanded. The clinical researcher's objective is the use of the PPG to guide early goal-directed therapeutic interventions (Ô¨Çuid, vasopressors, and inotropes), in effect to extract from the simple PPG the information and therapeutic guidance that was previously only obtainable from an arterial pressure line and the pulmonary artery catheter.
¬© 2014 Elsevier Ltd. All rights reserved.

* Corresponding author. E-mail addresses: aymen.alian@yale.edu (A.A. Alian), kirk.shelley@yale.edu (K.H. Shelley).
http://dx.doi.org/10.1016/j.bpa.2014.08.006 1521-6896/¬© 2014 Elsevier Ltd. All rights reserved.

396

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

Introduction

The photoplethysmographic (PPG) waveform is the core technology of the pulse oximeter. This wave is displayed on monitors throughout the critical care areas of the hospital (operating room (OR), emergency room (ER), postanesthesia care unit (PACU), intensive care unit (ICU), etc.). Unlike the electrocardiogram (ECG), it is rarely recorded or analyzed. This chapter endeavors to make the PPG waveform more useful to the practicing clinician. In addition, it explores some of the exciting research presently being carried out to expand its clinical usefulness.
At its heart, the PPG technology is remarkably simple consisting of a light source on one side of the tissue bed and a light detector on the other. Holding one hand in front of a bright light and looking at the red glow creates a PPG in its simplest and most accessible form. If your eyes were a bit more sensitive, you would see the subtle darkening of your hand with each heartbeat.

History
The PPG is not a new discovery [1,2]. It was Ô¨Årst described by Alrick Hertzman in 1937 [3]. This ultimately led to a remarkable series of papers by Hertzman [4e7] examining the physiology and potential uses of this waveform (Fig. 1). It was Hertzman who named it the photoelectric plethysmograph based upon his belief and early observations that its creation was linked to blood volume changes. He chose the term ‚Äúplethysmos,‚Äù which is derived from the Greek word for fullness. This expressed his belief that he was measuring the fullness of the tissue when he measured the amount of light absorption. Subsequent research has demonstrated he was not far off on his assumption with a close correlation (r ¬º 0.9) between the PPG and the more traditional strain gauge plethysmograph [8].
It is important to note that Hertzman was working from the simplistic model of light that was prevalent at the time. This was before the quantum complexities and scattering characteristics of light were generally appreciated [9]. His theories were derived from BeereLambert‚Äôs law of light, whose primary assumptions were that light absorption is directly proportional to the path length, concentration of substances, and the light absorption by each of those substances [10]. The modern day theory of light/tissue interaction is more complex and well laid out by Paul Mannheimer [11]. There are two major take-home messages to the practicing clinician: (1) there is more to the pulse oximeter waveform than a simple representation of the cardiac pulse (e.g., not just a ‚Äúpoor man's

Fig. 1. The photoelectric plethysmograph in position over the skin of the hand. From 1938 showing Hertzman's original setup for measuring the PPG (Used with permission from The American Physiology Society via Rightslink) [4].

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

397

arterial line‚Äù) [12] and (2) there is more to the PPG waveform than a simple display of tissue blood volume change [13] (although this is not a bad place to start when considering this waveform).
At this point, it is important to talk about some of the nomenclature used when describing the PPG particularly in the research literature. In the same way, Hertzman was inÔ¨Çuenced by his belief that he was measuring the ‚Äúfullness‚Äù of the tissue when he called his device a photoplethysmograph. Subsequent investigators also made some basic assumptions. One of those assumptions was that the only blood that caused modulation of the PPG was arterial. This component of the PPG was termed AC (after alternating current found in electrical circuits). This was the core assumption that allowed Takuo Aoyagi to develop the pulse oximeter in the 1970s [14]. The unchanging background absorption was labeled DC (for direct current). This simple deÔ¨Ånition has been a source of unending confusion. For example, how exactly is the DC measured? In the scientiÔ¨Åc literature, it has been measured at the troughs of the PPG, at the peaks (because of its normally inverted display), and at the mean of the PPG pulses. Subsequent research has demonstrated that venous blood also moves and modulates at the cardiac, respiratory, and autonomic frequencies [12,15,16]. This has unfortunately led to confusing nomenclature in the literature such as referring to the ratio of slowmodulating DC signals to cardiac modulations as DC% or the respiratory-induced intensity variations of the PPG as RIIV (Fig. 2). As our understanding of the fundamental physiology the PPG improves, hopefully so will our nomenclature.

Physiology
It should be stated up front that the unÔ¨Åltered PPG waveform is complex. It appears to be the end result of arterial and venous blood interaction with the cardiac, respiratory, and autonomic systems. The level of the vasculature that creates the signal is still an active area of research and debate [17]. The general consensus is that the cardiac component of the waveform comes from the site of maximum pulsation within the arteriolar vessels, where pulsatile energy is converted to smooth Ô¨Çow just before the level of the capillaries [18]. To this day, there is no known method of calibration of the PPG. This means one cannot directly compare the absolute numbers of one person's PPG to another's (e.g., people have different thicknesses of Ô¨Ångers, color of their skin, and amount of fat and muscle in their tissue). As the existence of the pulse oximeter demonstrates

Fig. 2. The components of a raw PPG waveform. The infrared waveform (~940 nm) is always displayed because of its stability. When this waveform is displayed on a clinical monitor, it is always inverted so that it goes in the same direction as the arterial pressure waveform. AC (as in alternating current) is the term given to the component that modulates at the cardiac frequency. The DC (as in direct current) refers to the steady-state light absorption of the tissue (i.e., bone, fat, and muscle). There is tremendous confusion regarding where exactly the DC should be measured from. Most people use the mean as illustrated here but it would be equally valid to use the top of the waveform (which actually corresponds to the diastole!). Note this diagram does not take into account the movement of venous blood or the effects of ventilation. This has led to a bewildering variety of nomenclature when discussing these types of phenomenon.

398

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

though, all is not lost; one can measure how the light absorption changes over time and the impact of various physiologic systems (cardiac, respiratory, and autonomic). One can also study these changes at different wavelengths to allow for the measurement of the ratio between substances (oxy vs. deoxyhemoglobin and plasma vs. total hemoglobin).

PPG display on modern clinical monitors

This naturally brings us to the question: what exactly is the clinician looking at on their clinical monitors when it comes to the PPG/Pleth/pulse oximeter waveform? First, the displayed waveform actually has little to do with the patient's oxygen saturation. The most frequent use of the PPG waveform is the examination of its regularity and pulsatile quality to detect artifacts potentially causing a low displayed oxygen saturation. As was explained to me by a senior professor during my anesthesia residency, the PPG waveform ‚Äútells you if your pulse oximeter is working‚Äù.
Given the degree of Ô¨Åltering that medical device manufacturers have elected to impose on this waveform, this should come as no surprise. Biomedical engineers, inÔ¨Çuenced by their marketing departments, have for the most part concluded that physicians are fairly simpleminded. It would appear they do not want to worry us with ‚Äúmessy details‚Äù and are striving to give us ‚Äúsmiley‚Äù versus ‚Äúfrowny‚Äù face displays to guide our therapeutic interventions. Unfortunately, part of their motivation might also be the protection of proprietary technology, not unlike William Morton in 1846 adding red dye and perfume to diethyl ether to create ‚ÄúLetheon‚Äù [19]. In the end, whatever the motivation, the result is the same; the clinician is presented with a simpliÔ¨Åed version of the patient's physiology.
Pulling back the curtain a bit, the PPG as displayed is the inverted infrared waveform (~940 nm), which has two major Ô¨Ålters on it. First, there is a band-pass Ô¨Ålter, eliminating slow gradual changes, as well as the fast spiky changes. In other words, the waveform is continually being smoothed and ‚Äúauto-centered.‚Äù Next, the waveform is having its size (amplitude) constantly being adjusted (e.g., ‚Äúauto-gain‚Äù). This is accomplished by two means, a modiÔ¨Åcation of its ampliÔ¨Åcation by the electronics and an adjustment of the light intensity of the light source (light-emitting diodes (LEDs)). If you have ever witnessed the pulse oximeter probe getting brighter and dimmer on a patient's Ô¨Ånger, this is a manifestation of the device attempting to determine the optimum light brightness of its LEDs.
Let us explore that a bit. It is important to understand what we are looking at and why. It is inverted so that the PPG looks like an arterial pressure waveform. In reality, with each heartbeat during systole, the amount of light that actually gets to the detector is less than during diastole. The clinician is shown the infrared waveform (as opposed to the red (~660 nm) waveform) precisely because it is inÔ¨Çuenced less by oxygen saturation. The infrared waveform can be thought of as the ‚Äúcalibrating‚Äù wavelength for the oxygen saturation calculation. It is Ô¨Åltered so that it does not drift off the screen, and so that the cardiac pulse is still clearly visible over a wide range of clinical conditions (vasodilated vs. vasoconstricted and weak pulse vs. a bounding one). Even in its standard, highly Ô¨Åltered presentation, it can still be quite useful for clinical care.

Cardiac arrhythmia, heart rate variability, and pulse transit time measurement

The PPG, on the standard clinical monitor, is an outstanding detector of cardiac arrhythmia [20]. In particular, it is very sensitive to any irregularity of the pulse. This is especially apparent if the patient is having premature ventricular or atrial beats (Fig. 3). It will allow for the rapid detection and diagnosis of atrial Ô¨Åbrillation, which is often difÔ¨Åcult to diagnose directly from the ECG. Its sensitivity and speciÔ¨Åcity signiÔ¨Åcantly improve with the concurrent display of the ECG. To the practicing clinician's advantage, the source of artifacts for devices (PPG and ECG) is very different. As an example, the ECG is sensitive to electrocautery, while the unshielded PPG can be inÔ¨Çuenced by infrared heating lamps. It is a rare situation that could simultaneously, and in a coordinated fashion, corrupt both waveforms.
Given the PPG sensitivity to heart irregularity, it has been observed that the PPG can be used to measure heart rate variability (HRV) and has a high degree of correlation with the ECG-derived HRV [21,22]. HRV, in turn, has been proposed as a monitor of the autonomic system and could potentially be

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

399

Fig. 3. The effect of cardiac arrhythmia (PVCs) on the PPG.
used for the early detection of shock [23]. Research efforts using the PPG as a source of measurement of HRV are still early, and they do not yet meet the standards of measurement suggested by cardiology societies [24].
Another intriguing use of the PPG, when combined with the ECG, is the measurement of pulse velocity through the body [25]. Called the pulse transit time (PTT), it is obtained by measuring how long it takes the PPG to arrive at a distal portion of the body (i.e., Ô¨Ånger or toe). It is calculated by using the QRS of the ECG as the start time and the upward deÔ¨Çection of the PPG marking the arrival of the pulse. Short PTTs have been associated with high blood pressure, aging, arterial sclerosis, and diabetes [26], the basic observation being that the stiffer the vessel, the more rapidly the pulse will travel through it [27]. PTT has been proposed as a method of following rapidly changing blood pressure noninvasively during anesthesia induction [28] or spinal anesthesia [29]. As a continuous monitor of noninvasive blood pressure, the results from PPG analysis alone have been disappointing and would appear to require frequent calibration [30,31]. Given the complexity of the underlying physiology, we would be surprised if a new method of analysis were developed that would allow for continuous blood pressure measurement.
PPG pulse amplitude
One of the prominent features of the PPG is the size of the pulse beat. It is sometimes referred to as pulse amplitude or pulse height. Unfortunately, given the tendencies of medical device manufacturers to Ô¨Ålter the PPG, and speciÔ¨Åcally use ‚Äúauto-gain‚Äù or ‚Äúauto-ampliÔ¨Åcation,‚Äù this limits its usability by the practicing clinician. Early pulse oximeters, such as the Oxipleth by Novametrix, had the ability to have the user turn off or lock the degree of ampliÔ¨Åcation. Masimo, in its pulse oximeters, has introduced the measurement of a ‚Äúperfusion index‚Äù (PI) that can be used, in a limited manner, as a substitute for an amplitude measurement. Physiologically, the PPG amplitude is as a result of a complex interaction of stroke volume, vascular compliance, and tissue congestion effects. Table 1 summarizes the conditions that tend to affect PPG pulse amplitude. Importantly, the PPG has been shown to be sensitive to even small amounts of pulsatile blood Ô¨Çow (as small as 4% of the baseline as determined by laser Doppler) [32,33]. One should never confuse a large PPG pulse with a high arterial pressure. It is not unusual for the PPG amplitude to decrease during signiÔ¨Åcant increases in blood pressure that are due to increased sympathetic tone. In addition, while clearly being related to cardiac stroke volume especially at the extremes, there appear to be too many confounding factors to allow for the creation of a direct linear relationship between the PPG pulse and cardiac output [34e37].
The above limitations do not preclude one from using the PPG to estimate the systolic blood pressure. This is done by using the ability of the PPG to detect a peripheral pulse. Using a manually

400

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

Table 1 Factors affecting PPG pulse amplitude.
 Decreased amplitude (smaller pulses)
B Vasoconstriction ‚ñ™ Pharmacological: phenylephrine, ephedrine ‚ñ™ Physiological: cold, surgical-induced stress

B Increased tissue congestion (venous) ‚ñ™ Hand position lower than the heart (when measured at the Ô¨Ånger) ‚ñ™ Trendelenburg position (when measured at the ear) ‚ñ™ Abdominal Laparoscopy ‚ñ™ Valsalva maneuver

B Low stroke volume (when critically reduced)  Increased amplitude (larger pulses)

B Vasodilation ‚ñ™ Pharmacological: nitroprusside ‚ñ™ Physiologic: warming, sedation, sepsis ‚ñ™ Anesthetic: regional blocks

B Decreased tissue congestion (venous) ‚ñ™ Hand position held above the heart (when measured at the Ô¨Ånger)

controlled blood pressure cuff with the PPG Ô¨Ånger probe on the same side, one inÔ¨Çates the cuff until all signs of cardiac pulsations are absent from the PPG. The blood pressure cuff is then slowly deÔ¨Çated until the pulse is once again detected. This pressure has a high correlation to the systolic blood pressure (r ¬º 0.9) [38,39]. This technique has been found to be helpful both in noisy environments and with neonates because of the difÔ¨Åculty of using stethoscopes [40].
PPG morphology
Within the PPG pulse morphology, there are a number of interesting features. Like the arterial line, pressure in the dicrotic notch (incisura) can often be identiÔ¨Åed. The review paper on the PPG, by Murray [41], has an excellent discussion on the interpretation of the presence and location of this feature. He relates the dicrotic notch position to vascular tone. Supported by the analysis of arterial pressure waveforms by the physiologist O'Rourke [42,43], he reports that a high arterial vascular tone (low compliance) is associated with the notch occurring early and high up on the downward diastolic curve. On rare occasions, one can even Ô¨Ånd hyperresonate notches that occur in both the arterial pressure waveform and the PPG. They are located just before, or just after, the systolic peak and have also been associated with high vascular tone. Some investigators have even gone so far as to analyze the speed of change in the PPG (as measured by the second derivative) to detect the impact of aging and hypertension, as well as to monitor drug effects [44,45].
In contrast to the arterial pressure waveform, the PPG can also display venous pressure waveform characteristics. These are often Ô¨Årst detected by the presence of large peaks during diastole [12]. In the presence of hypervolemia, high abdominal pressure (laparoscopic surgery), and heads-down position (Trendelenburg), the PPG can take on CVP waveform (aecev) characteristics that interfere with the function of the pulse oximeter [46].
Assuming one is capable of measuring the PPG amplitude, which has been minimally Ô¨Åltered, the next consideration is the region of the body where it is being measured. In the Ô¨Ånger, where the
walls of the cutaneous vessels are richly innervated by a-adrenoceptors, the sensitivity to changes
in the sympathetic system are greater than when compared to other areas of the body such as the earlobe [47]. Once a baseline measurement has been established, the pulse oximeter amplitude can be followed as a monitor of vascular sympathetic tone [48,49]. An intriguing potential use of the plethysmograph may be as an indicator of minimum alveolar concentration-blockade adrenergic

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

401

response (MAC-BAR) [50], the dose of anesthetic required to block adrenergic response in 50% of individuals who have a surgical skin incision. The degree of sympathetic responsiveness a patient retains during anesthesia might have important clinical implications. Another, and related, use of the PPG is the detection of the success and duration of spinal, epidural, and regional anesthetics [51e54].

PPG & functional hemodynamics

One of the most promising avenues of investigation is the exploration of the interaction between the PPG waveform and the respiratory system. Based upon the principles of functional hemodynamics [55], it is hoped that early goal-directed therapy will allow for improved patient outcomes [56,57]. The PPG efforts are based upon the success of using the arterial line pressure waveform to determine the patient's Ô¨Çuid responsiveness (answering the fundamental question of whether the cardiac output will go up if the patient is given intravenous Ô¨Çuid?) [58,59]. Early research in this direction has been quite promising [60e63] (Fig. 4). With further investigations, it has become apparent that the PPG, while providing a good predictive power regarding Ô¨Çuid responsiveness under stable and controlled conditions (‚Äúon the riÔ¨Çe range‚Äù), tends to become unstable and susceptible to artifacts in the dynamic situations found in a typical OR or ICU (‚Äúin the jungle‚Äù) [64e68].
The authors of this chapter have spent a number of years examining this speciÔ¨Åc use of the PPG (using respiratory-induced modulation to predict the requirement for additional intravenous Ô¨Çuid).

Fig. 4. The effects of acute hypovolemia (i.e., bleeding) on the PPG. It is from a patient who suffered a sudden blood loss (~500 cc) during a surgical procedure. It demonstrates a shift from a simple baseline venous modulation (A) to a combined arterial and venous modulation (B).

402

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

We have come to the conclusion that three parallel investigations are needed. First, there needs to be an improved understanding of the physiology behind the modulation of the PPG waveform. This speciÔ¨Åcally needs to be focused on what components of the modulation are associated with the peripheral movement of venous and arterial blood (during both spontaneous and mechanical ventilation) and how these modulations interact with the autonomic system (awake vs. anesthetized patients) [69]. Second, there is a need for an improved understanding of how the airway pressure and tidal volumes interact with both the pulmonary and systemic cardiovascular systems [55,58]. Third, improved electronics and digital signal processing techniques are needed to isolate these respiratory-induced changes in these challenging real-world environments [70].
This naturally leads to the question: is there a way for the practicing anesthesiologist to use these insights regarding PPG ventilator-induced modulations in today's OR? The key to answering this question is understanding the source of sensitivity (false negatives) and speciÔ¨Åcity (false positives) of this measurement. Regarding the sensitivity, it is clear that the patient needs to undergo mechanical ventilation [71], using a controlled volume mode [72] with adequate tidal volume breaths (>8 cc/kg) [73]. Once these conditions are met, one can decide/measure if a signiÔ¨Åcant degree of modulation is occurring. The clinical cutoff appears to be approximately 15% [74,75]. Interestingly, there is a fair amount of debate whether or not a clinician can just ‚Äúeyeball‚Äù the screen for a measurement of waveform modulation [76,77]. Our recommendation would be to either slow the scroll speed (<12.5 cm/s) of the screen or print out the PPG, using a strip chart recorder (once again using a slower printing speed). The key observation here is that if there is little or no modulation, despite adequate ventilation, one can be conÔ¨Ådent that the patient is not hypovolemic. In other words, there are very few causes (none as far as we know) for a ‚Äúfalse negative‚Äù. On the other hand, if the wave is modulating (rocking up and down), hypovolemia is among the leading causes for this but not the only cause. One also has to consider the potential for other causes such as cardiac tamponade, asthma, high airway pressures, and tension pneumothorax [78].

Research considerations

For research purposes, there are two basic methods of analysis that can used to analyze the PPG waveform, namely time domain and frequency domain [79,80]. In the time domain analysis, the key features of the PPG waveforms that are measured include amplitude (related to pulse pressure/SV/ vascular compliance), area, width (at either the base or 50% height), as well as maximum slope (related to dP/dT) and minimum slope (related to the speed of vessel relaxation and blood run). With frequency domain analysis, for example, using Fourier transformation, the PPG waveforms can be described as the sum of simpler underlying harmonics (sine and cosine waves). The advantage of this approach is the powerful assumption that the PPG waveform is due to two physiologic metronomes, the heart and the lungs (especially during mechanical ventilation) [81].
There is the intriguing possibility of using PPG to measure vascular compliance in both arteries and veins by combining its volumetric information with pressure measurements taken directly from the vessel or from a blood pressure cuff [82]. The venous/arterial compliance ratio can be calculated by assuming that the baseline modulation (DC) of the PPG at the respiratory frequency (0.1e0.4 Hz) is due to changes in venous blood volume while cardiac modulations (AC) of the PPG (0.8e2.5 Hz) are due to changes in arterial blood volume. This information is then combined with the pressure information from a peripheral venous pressure waveform and a blood pressure cuff to calculate the compliance ratio [83].
Another active line of investigation includes relating the preload information from venous modulation (DC/respiratory modulation) to stroke volume variation present in the cardiac portion of the PPG (AC/SV modulation). From this work, it is hoped that information regarding cardiac function and the Starling curve might be obtained noninvasively [83].
One of the most exciting avenues of research at the moment is the development of the pulse oximeter camera [84e87]. These are noncontact systems that would allow for the detection of the PPG at a distance, using either ambient light or infrared spotlights. The potential for such systems is remarkable, particularly in the Ô¨Åeld of public health. Consider the potential for monitoring, noninvasively and nonintrusively, the waiting room of a crowded ER or passengers on a long-distance airplane Ô¨Çight. This technology has a strong ‚ÄúStar Trek‚Äù medical tricorder feel to it.

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

403

Practice points
 While the PPG is often thought of as a substitute for an arterial line pressure measurement, in reality it is a volumetric signal, measuring how big the Ô¨Ånger or ear blood vessels (arterial and venous) become with each heartbeat and breath.
 With the modern pulse oximeter, the PPG is a highly Ô¨Åltered waveform with both autocentering and auto-gain adjustments being made continuously.
 The PPG is exquisitely sensitive to any change in cardiac rhythm. It is an excellent detector of irregular heartbeats such as PVCs, PACs, and A-Ô¨Åb especially when used in conjunction with the electrocardiogram.
 On some clinical monitors, the PPG can be examined for modulations during routine positive pressure ventilation; if absent, it is unlikely the patient is hypovolemic.
 The size (height or amplitude) of the PPG pulse reÔ¨Çects the interaction of the cardiac stroke volume and local vascular compliance.
 The medical device manufacturers have to be convinced that practicing clinicians should have access to more display options (Ô¨Ålter settings, scroll speed, wavelength selection, and AC and DC values) when it comes to the PPG waveform.

Research agenda
 As remarkable as it might sound, the physiologic source of the PPG waveform is still unknown. The determination of the true physiologic source of the PPG waveform is a high priority.
 We lack the ability to calibrate the PPG. This leaves us with only the capability to monitor changes over time such as those caused by the cardiac pulse or pulmonary ventilation. Using multiple wavelengths, we can determine the ratios of substances but not their absolute measurements. The development of the capacity to calibrate the PPG waveform would unlock the true potential of this signal.
 Further research efforts are needed regarding the potential use of the PPG in early goaldirected interventions based upon the principles of functional hemodynamics.
 The three most promising avenues of investigation (in order of their present maturity) include optimization of the patients' (1) blood volume, (2) vascular tone, and (3) cardiac function.
 Pulse oximeter cameras (noncontact systems), while still in their infancy, appear to hold tremendous promise for the future of this waveform. Personally, we are convinced that Dr. McCoy's medical tricorder from Star Trek is, in actuality, a photoplethysmographic device.
References
[1] Severinghaus JW, Astrup PB. History of blood gas analysis. VI. Oximetry. J Clin Monit 1986;2(4):270e88. [2] Wukitsch MW. Pulse oximetry: historical review and Ohmeda functional analysis. Int J Clin Monit Comput 1987;4(3):
161e6. [3] Hertzman AB, Spielman C. Observations on the Ô¨Ånger volume pulse recorded photoelectrically. Am J Physiol 1937;119:
334e5. [4] Hertzman AB. The blood supply of various skin areas as estimated by the photoelectric plethysmograph. Am J Physiol
1938;124(2):328e40. [5] Hertzman AB, Dillon JB. Distinction between arterial, venous, and Ô¨Çow components in photoelectric plethysmography in
man. Am J Physiol 1940;130(1):177e85. [6] Hertzman AB, Dillon JB. Applications of photoelectric plethysmography in peripheral vascular disease. Am J Physiol 1940:
750e61. [7] Hertzman AB, Roth LW. The absence of vasoconstrictor reÔ¨Çexes in the forehead circulation: effects of cold. Am J Physiol
1942;136:692e7.

404

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

[8] de Trafford J, Lafferty K. What does photoplethysmography measure? Med Biol Eng Comput 1984;22(5):479e80. [9] Schmitt JM. Simple photon diffusion analysis of the effects of multiple scattering on pulse oximetry. IEEE Trans Biomed
Eng 1991;38(12):1194e203. [10] August B. Versuch der absorptions-verhaltnisse des cordierites fur rothes licht zu bestimmen. Ann Physik Chem Ger 1851;
84:37e52. *[11] Mannheimer PD. The light tissue interaction of pulse oximetry. Anesth Analg 2007;105(6S_Suppl.):S10e7.
[12] Shelley KH, Dickstein M, Shulman SM. The detection of peripheral venous pulsation using the pulse oximeter as a plethysmograph. J Clin Monit 1993;9(4):283e7.
[13] Nijboer JA, Dorlas JC, Mahieu HF. Photoelectric plethysmographyesome fundamental aspects of the reÔ¨Çection and transmission method. Clin Phys Physiol Meas 1981;2(3):205e15.
*[14] Aoyagi T. Pulse oximetry: its invention, theory, and future. J Anesth 2003;17(4):259e66. [15] Shelley K, Tamai D, Jablonka D, et al. The effect of venous pulsation on the forehead pulse oximeter wave form as a possible source of error in SPo2 calculation. Anesth Analgesia 2005;100(3):743e7. [16] Walton ZD, Kyriacou PA, Silverman DG, et al. Measuring venous oxygenation using the photoplethysmograph waveform. J Clin Monit Comput 2010;24(4):295e303. [17] Kim JM, Arakawa K, Benson KT, et al. Pulse oximetry and circulatory kinetics associated with pulse volume amplitude measured by photoelectric plethysmography. Anesth Analg 1986;65(12):1333e9. [18] Spigulis J. Optical noninvasive monitoring of skin blood pulsations. Appl Opt 2005;44(10):1850e7.
*[19] Ruskin KJ, Shelley KH. Patent medicine and the ''Black Box. Anesth Analg 2005;100(5):1361e2. *[20] Shelley KH. Photoplethysmography: beyond the calculation of arterial oxygen saturation and heart rate. Anesth Analg
2007;105(6 Suppl.):S31e6. [21] Lu S, Zhao H, Ju K, et al. Can photoplethysmography variability serve as an alternative approach to obtain heart rate
variability information? J Clin Monit Comput 2008;22(1):23e9. [22] Nitzan M, Babchenko A, Khanokh B, et al. The variability of the photoplethysmographic signalea potential method for the
evaluation of the autonomic nervous system. Physiol Meas 1998;19(1):93e102. [23] Cooke WH, Convertino VA. Heart rate variability and spontaneous baroreÔ¨Çex sequences: implications for autonomic
monitoring during hemorrhage. J Trauma 2005;58(4):798e805. [24] Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European
society of cardiology and the North American society of pacing and electrophysiology. Circulation 1996;93(5):1043e65. [25] Naschitz JE, Bezobchuk S, MussaÔ¨Åa-Priselac R, et al. Pulse transit time by R-wave-gated infrared photoplethysmography:
review of the literature and personal experience. J Clin Monit Comput 2005;18(5e6):333. [26] Mitchell A, Opazo Saez A, Kos M, et al. Pulse wave velocity predicts mortality in renal transplant patients. Eur J Med Res
2010;15(10):452e5. [27] Nitzan M, Khanokh B, Slovik Y. The difference in pulse transit time to the toe and Ô¨Ånger measured by photo-
plethysmography. Physiol Meas 2002;23(1):85e93. [28] Kim SH, Song JG, Park JH, et al. Beat-to-beat tracking of systolic blood pressure using noninvasive pulse transit time
during anesthesia induction in hypertensive patients. Anesth Analg 2013;116(1):94e100. [29] Sharwood-Smith G, Bruce J, Drummond G. Assessment of pulse transit time to indicate cardiovascular changes during
obstetric spinal anaesthesia. Br J Anaesth 2006;96(1):100e5. [30] Young CC, Mark JB, White W, et al. Clinical evaluation of continuous noninvasive blood pressure monitoring: accuracy
and tracking capabilities. J Clin Monit 1995;11(4):245e52. [31] Awad A, Ghobashy MA, Stout RG, et al. How does the plethysmogram derived from the pulse oximeter relate to arterial
blood pressure in coronary artery bypass graft patients? Anesth Analg 2001;93(6):1466e71. [32] Lawson D, Norley I, Korbon G, et al. Blood Ô¨Çow limits and pulse oximeter signal detection. Anesthesiology 1987;67(4):
599e603. [33] Palve H, Vuori A. Minimum pulse pressure and peripheral temperature needed for pulse oximetry during cardiac surgery
with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1991;5(4):327e30. [34] Awad AA, Stout RG, Ghobashy MA, et al. Analysis of the ear pulse oximeter waveform. J Clin Monit Comput 2006;20(3):175e84. [35] Azabji Kenfack M, Lador F, Licker M, et al. Cardiac output by modelÔ¨Çow method from intra-arterial and Ô¨Ångertip pulse
pressure proÔ¨Åles. Clin Sci (Lond) 2004;106(4):365e9. [36] McGrath SP, Ryan KL, Wendelken SM, et al. Pulse oximeter plethysmographic waveform changes in awake, spontaneously
breathing, hypovolemic volunteers. Anesth Analg 2011;112(2):368e74. [37] Thiele RH, Colquhoun DA, Patrie J, et al. Relationship between plethysmographic waveform changes and hemodynamic
variables in anesthetized, mechanically ventilated patients undergoing continuous cardiac output monitoring. J Cardiothorac Vasc Anesth 2011;25(6):1044e50. [38] Talke P, Nichols RJ, Traber D. Does measurement of systolic blood pressure with a pulse oximeter correlate with conventional methods? J Clin Monit 1990;6(1):5e9. [39] Wallace C, Baker J, Alpert C. Comparison of blood pressure measurement by Doppler and by pulse oximetry techniques. Anesth Analg 1987;66:1018e9. [40] Mohler J, Hart SC. Use of a pulse oximeter for determination of systolic blood pressure in a helicopter air ambulance. Air Med J 1994;13(11e12):479e82. *[41] Murray WB, Foster PA. The peripheral pulse wave: information overlooked. J Clin Monit 1996;12(5):365e77. [42] O'Rourke M, Yaginuma T. Wave reÔ¨Çections and the arterial pulse. Arch Intern Med 1984;144:366e71. [43] O'Rourke MF. Time domain analysis of the arterial pulse in clinical medicine. Med Biol Eng Comput 2009;47(2):119e29. [44] Hashimoto J, Watabe D, Kimura A, et al. Determinants of the second derivative of the Ô¨Ånger photoplethysmogram and brachial-ankle pulse-wave velocity: the Ohasama study. Am J Hypertens 2005;18(4 Pt 1):477e85. [45] Takazawa K, Tanaka N, Fujita M, et al. Assessment of vasoactive agents and vascular aging by the second derivative of photoplethysmogram waveform. Hypertension 1998;32(2):365e70. [46] Shelley KH, Tamai D, Jablonka D, et al. The effect of venous pulsation on the forehead pulse oximeter wave form as a possible source of error in SpO2 calculation. Anesth Analg 2005;100(3):743e7.

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

405

[47] Awad A, Ghobashy M, Ouda W, et al. Different responses of ear and finger pulse oximeter wave form to cold presser test. Anesth Analg 2001;92(6):1483e6.
[48] Ezri T, Steinmetz A, Geva D, et al. Skin vasomotor reÔ¨Çex as a measure of depth of anesthesia, in. Anesthesiology 1998: 1281e2.
[49] Luginbuhl M, Reichlin F, Sigurdsson GH, et al. Prediction of the haemodynamic response to tracheal intubation: comparison of laser-Doppler skin vasomotor reÔ¨Çex and pulse wave reÔ¨Çex. Br J Anaesth 2002;89(3):389e97.
[50] Roizen MF, Horrigan RW, Frazer BM. Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incisioneMAC BAR. Anesthesiology 1981;54(5):390e8.
[51] Galvin EM, Niehof S, Verbrugge SJ, et al. Peripheral Ô¨Çow index is a reliable and early indicator of regional block success. Anesth Analg 2006;103(1):239e243, [table of contents].
[52] Okuda Y, Kitajima Y, Asai T. Use of a pulse oximeter during performance of an axillary plexus block. Anaesthesia 1997; 52(7):717e8.
[53] Kim J-M, LaSalle AD, Parmley RT. Sympathetic recovery following lumbar epidural and spinal anagesia. Anesth Analg 1977;56(3):352e5.
[54] Kim J-M, Arakawa K, VonLintel T. Use of the pulse-wave monitor as a measurement of diagnostic sympathetic block and of surgical sympathectomy. Anesth Analg 1975;54(3):289e96.
[55] Pinsky MR, Payen D. Functional hemodynamic monitoring. Crit Care 2005;9(6):566e72. *[56] Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic
intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg 2011;112(6): 1392e402. *[57] Gan TJ, Soppitt A, Maroof M, et al. Goal-directed intraoperative Ô¨Çuid administration reduces length of hospital stay after major surgery. Anesthesiology 2002;97(4):820e6. *[58] Michard F. Changes in arterial pressure during mechanical ventilation. Anesthesiology 2005;103(2):419e28. [59] Preisman S, Kogan S, Berkenstadt H, et al. Predicting Ô¨Çuid responsiveness in patients undergoing cardiac surgery: functional haemodynamic parameters including the respiratory systolic variation test and static preload indicators. Br J Anaesth 2005;95(6):746e55. [60] Cannesson M, Attof Y, Rosamel P, et al. Respiratory variations in pulse oximetry plethysmographic waveform amplitude to predict Ô¨Çuid responsiveness in the operating room. Anesthesiology 2007;106(6):1105e11. [61] Feissel M, Kalakhy R, Banwarth P, et al. Plethysmographic variation index predicts Ô¨Çuid responsiveness in ventilated patients in the early phase of septic shock in the emergency department: a pilot study. J Crit Care 2013;28(5):634e9. [62] Sandroni C, Cavallaro F, Marano C, et al. Accuracy of plethysmographic indices as predictors of Ô¨Çuid responsiveness in mechanically ventilated adults: a systematic review and meta-analysis. Intensive Care Med 2012;38(9):1429e37. [63] Loupec T, Nanadoumgar H, Frasca D, et al. Pleth variability index predicts fluid responsiveness in critically ill patients. Crit Care Med 2011;39(2):294e9. [64] Hood JA, Wilson JT. Pleth variability index to predict Ô¨Çuid responsiveness in colorectal surgery. Anesth Analg 2011;113: 1058e63. [65] Hengy B, Gazon M, Schmitt Z, et al. Comparison between respiratory variations in pulse oximetry plethysmographic waveform amplitude and arterial pulse pressure during major abdominal surgery. Anesthesiology 2012;117(5):973e80. [66] Landsverk SA, Hoiseth LO, Kvandal P, et al. Poor agreement between respiratory variations in pulse oximetry photoplethysmographic waveform amplitude and pulse pressure in intensive care unit patients. Anesthesiology 2008;109(5): 849e55. [67] Thiele RH, Colquhoun DA, Forkin KT, et al. Assessment of the agreement between photoplethysmographic and arterial waveform respiratory variation in patients undergoing spine surgery. J Med Eng Technol 2013;37(7):409e15. [68] Monnet X, Guerin L, Jozwiak M, et al. Pleth variability index is a weak predictor of Ô¨Çuid responsiveness in patients receiving norepinephrine. Br J Anaesth 2013;110(2):207e13. [69] Shelley KH, Alian AA, Shelley AJ. Role of the photoplethysmographic waveform in the care of high-risk surgical patients. Anesthesiology 2013;118(6):1479e80. [70] Cannesson M, Awad AA, Shelley K. Oscillations in the plethysmographic waveform amplitude: phenomenon hides behind artifacts. Anesthesiology 2009;111(1):206e7. *[71] Nilsson L, Goscinski T, Lindenberger M, et al. Respiratory variations in the photoplethysmographic waveform: acute hypovolaemia during spontaneous breathing is not detected. Physiol Meas 2010;31(7):953e62. [72] Perner A, Faber T. Stroke volume variation does not predict Ô¨Çuid responsiveness in patients with septic shock on pressure support ventilation. Acta Anaesthesiol Scand 2006;50(9):1068e73. [73] Reuter DA, Bayerlein J, Goepfert MS, et al. InÔ¨Çuence of tidal volume on left ventricular stroke volume variation measured by pulse contour analysis in mechanically ventilated patients. Intensive Care Med 2003;29(3):476e80. [74] Cannesson M, Le Manach Y, Hofer CK, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of Ô¨Çuid responsiveness: a ''Gray Zone. Approach Anesthesiol 2011;115(2):231e41. [75] Desebbe O, Cannesson M. Using ventilation-induced plethysmographic variations to optimize patient Ô¨Çuid status. Curr Opin Anaesthesiol 2008;21(6):772e8. [76] Rinehart J, Islam T, Boud R, et al. Visual estimation of pulse pressure variation is not reliable: a randomized simulation study. J Clin Monit Comput 2012;26(3):191e6. [77] Thiele RH, Colquhoun DA, Blum FE, et al. The ability of anesthesia providers to visually estimate systolic pressure variability using the ‚Äúeyeball‚Äù technique. Anesth Analg 2012;115(1):176e81. [78] Khasnis A, Lokhandwala Y. Clinical signs in medicine: pulsus paradoxus. J Postgrad Med 2002;48(1):46e9. [79] Alian AA, Galante NJ, Stachenfeld NS, et al. Impact of central hypovolemia on photoplethysmographic waveform parameters in healthy volunteers. Part 1: time domain analysis. J Clin Monit Comput 2011;25(6):377e85. [80] Alian AA, Galante NJ, Stachenfeld NS, et al. Impact of central hypovolemia on photoplethysmographic waveform parameters in healthy volunteers part 2: frequency domain analysis. J Clin Monit Comput 2011;25(6):387e96. [81] Shelley KH, Awad AA, Stout RG, et al. The use of joint time frequency analysis to quantify the effect of ventilation on the pulse oximeter waveform. J Clin Monit Comput 2006;20(2):81e7.

406

A.A. Alian, K.H. Shelley / Best Practice & Research Clinical Anaesthesiology 28 (2014) 395e406

[82] Shelley KH, Murray WB, Chang D. Arterial-pulse oximetry loops: a new method of monitoring vascular tone. J Clin Monit 1997;13(4):223e8.
[83] Shelley K, Silverman D. Apparatus, systems and methods analyzing pressure and volume waveforms in the vasculature. United States Patent OfÔ¨Åce, Jul 18, 2013. US 13/809,687(US20130184594 A1).
[84] Holton BD, Mannapperuma K, Lesniewski PJ, et al. Signal recovery in imaging photoplethysmography. Physiol Meas 2013; 34(11):1499e511.
[85] Aarts LA, Jeanne V, Cleary JP, et al. Non-contact heart rate monitoring utilizing camera photoplethysmography in the neonatal intensive care unit e a pilot study. Early Hum Dev 2013;89(12):943e8.
*[86] Wieringa FP, Mastik F, van der Steen AF. Contactless multiple wavelength photoplethysmographic imaging: a Ô¨Årst step toward ‚ÄúSpO2 camera‚Äù technology. Ann Biomed Eng 2005;33(8):1034e41.
[87] Poh MZ, McDuff DJ, Picard RW. Non-contact, automated cardiac pulse measurements using video imaging and blind source separation. Opt Express 2010;18(10):10762e74.

